Phase II study of axitinib in patients with neurofibromatosis type 2-related schwannomatosis and progressive vestibular schwannomas Meeting Abstract


Authors: Garcia, M. R.; Hagiwara, M.; Yaffe, A.; Mitchell, C.; Akshintala, S.; Nicolaides, T.; Phadnis, S. S.; Yohay, K.; Feng, Y.; Goldberg, J. D.; Allen, J. C.; Karajannis, M. A.
Abstract Title: Phase II study of axitinib in patients with neurofibromatosis type 2-related schwannomatosis and progressive vestibular schwannomas
Meeting Title: 21st International Symposium on Pediatric Neuro-Oncology (ISPNO 2024)
Journal Title: Neuro-Oncology
Volume: 26
Issue: Suppl. 4
Meeting Dates: 2024 Jun 28-July 2
Meeting Location: Philadelphia, PA
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2024-06-01
Language: English
ACCESSION: WOS:001252720000146
DOI: 10.1093/neuonc/noae064.569
PROVIDER: wos
Notes: Meeting Abstract: NFS-11 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors